|
FH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.2924556938101E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.98432414733452E-12 |
| Normal-vs-Stage2 |
8.096200E-01 |
| Normal-vs-Stage3 |
6.39943653624186E-12 |
| Normal-vs-Stage4 |
2.10830242153293E-11 |
| Stage1-vs-Stage2 |
2.458100E-03 |
| Stage1-vs-Stage3 |
3.572800E-01 |
| Stage1-vs-Stage4 |
1.345180E-01 |
| Stage2-vs-Stage3 |
9.955700E-04 |
| Stage2-vs-Stage4 |
4.615600E-04 |
| Stage3-vs-Stage4 |
5.555200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.43058914609173E-14 |
| Normal-vs-AfricanAmerican |
1.20749999998893E-06 |
| Normal-vs-Asian |
2.86589999509701E-08 |
| Caucasian-vs-AfricanAmerican |
4.517800E-01 |
| Caucasian-vs-Asian |
9.260000E-01 |
| AfricanAmerican-vs-Asian |
5.362800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.31199999992604E-07 |
| Normal-vs-Female |
1.19609877557991E-11 |
| Male-vs-Female |
7.907000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.30437890991197E-12 |
| Normal-vs-Age(41-60Yrs) |
4.88653562058516E-12 |
| Normal-vs-Age(61-80Yrs) |
5.332100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.537860E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.386400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.516600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.362800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.817800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.427200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.457640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.417000E-03 |
| Classical-VS-Follicular |
8.39929999996158E-07 |
| Classical-VS-Other |
7.184600E-01 |
| Classical-VS-Normal |
5.6621374255883E-15 |
| Tall-VS-Follicular |
2.53950005468795E-09 |
| Tall-VS-Other |
7.260600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.830000E-02 |
| Follicular-VS-Normal |
7.900600E-01 |
| Other-VS-Normal |
8.436200000006E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.26390000079846E-08 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
5.79119999954969E-07 |
|
|
